Target intelligence / Profile preview

Butyrophilin Subfamily 3 Member A (BTN3A)

Target
BTN3A
Molecular classification
Immunoglobulin Superfamily, Type I transmembrane protein, Cell surface receptor
01

Overview

Butyrophilin subfamily 3 member A (BTN3A) refers to a family of cell surface proteins, including BTN3A1, BTN3A2, and BTN3A3. These molecules are part of the immunoglobulin superfamily and are closely related to the B7 co-stimulatory family. They play critical roles in immune regulation, particularly in modulating T cell responses and γδ T cell activation. BTN3A acts as an immune checkpoint molecule with implications for cancer prognosis and therapy response prediction.

Other names
CD277BTN3A1BTN3A2BTN3A3CD277aBTF5
02

Mechanism of action

Nivolumab binds to PD-1 and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 mediated inhibition of the anti-tumor immune response.

03

Biological functions

Immune regulationT cell activationγδ T cell activationPhosphoantigen sensingCytokine production regulation
04

Disease associations

CancerImmune disorders
05

Interacting drugs

06

Biomarkers

BTN3A expression levels (predictive of nivolumab response)

Beyond the preview

Go deeper on Butyrophilin Subfamily 3 Member A (BTN3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Butyrophilin Subfamily 3 Member A (BTN3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call